Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study
- PMID: 33089862
- PMCID: PMC7665717
- DOI: 10.1093/schbul/sbaa158
Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study
Abstract
Patients with schizophrenia (SCZ) represent a vulnerable population who have been understudied in COVID-19 research. We aimed to establish whether health outcomes and care differed between patients with SCZ and patients without a diagnosis of severe mental illness. We conducted a population-based cohort study of all patients with identified COVID-19 and respiratory symptoms who were hospitalized in France between February and June 2020. Cases were patients who had a diagnosis of SCZ. Controls were patients who did not have a diagnosis of severe mental illness. The outcomes were in-hospital mortality and intensive care unit (ICU) admission. A total of 50 750 patients were included, of whom 823 were SCZ patients (1.6%). The SCZ patients had an increased in-hospital mortality (25.6% vs 21.7%; adjusted OR 1.30 [95% CI, 1.08-1.56], P = .0093) and a decreased ICU admission rate (23.7% vs 28.4%; adjusted OR, 0.75 [95% CI, 0.62-0.91], P = .0062) compared with controls. Significant interactions between SCZ and age for mortality and ICU admission were observed (P = .0006 and P < .0001). SCZ patients between 65 and 80 years had a significantly higher risk of death than controls of the same age (+7.89%). SCZ patients younger than 55 years had more ICU admissions (+13.93%) and SCZ patients between 65 and 80 years and older than 80 years had less ICU admissions than controls of the same age (-15.44% and -5.93%, respectively). Our findings report the existence of disparities in health and health care between SCZ patients and patients without a diagnosis of severe mental illness. These disparities differed according to the age and clinical profile of SCZ patients, suggesting the importance of personalized COVID-19 clinical management and health care strategies before, during, and after hospitalization for reducing health disparities in this vulnerable population.
Keywords: COVID-19; health services research; psychiatry; public health; real-life data; schizophrenia.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures



Similar articles
-
Increased in-hospital mortality from COVID-19 in patients with schizophrenia.Encephale. 2021 Apr;47(2):89-95. doi: 10.1016/j.encep.2020.07.003. Epub 2020 Jul 30. Encephale. 2021. PMID: 32933762 Free PMC article.
-
[Mortality in schizophrenia: Towards a new health scandal? COVID-19 and schizophrenia].Ann Med Psychol (Paris). 2021 Apr;179(4):353-362. doi: 10.1016/j.amp.2021.02.016. Epub 2021 Feb 17. Ann Med Psychol (Paris). 2021. PMID: 33753948 Free PMC article. French.
-
Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data.Lancet Respir Med. 2021 Apr;9(4):407-418. doi: 10.1016/S2213-2600(20)30560-9. Epub 2021 Jan 15. Lancet Respir Med. 2021. PMID: 33460571 Free PMC article.
-
Do patients with schizophrenia have higher infection and mortality rates due to COVID-19? A systematic review.Psychiatriki. 2021 Sep 20;32(3):219-223. doi: 10.22365/jpsych.2021.027. Epub 2021 Aug 5. Psychiatriki. 2021. PMID: 34390554
-
[Too old for the intensive care unit? Backgrounds and challenges].Ned Tijdschr Geneeskd. 2019 Oct 29;163:D4021. Ned Tijdschr Geneeskd. 2019. PMID: 31714040 Review. Dutch.
Cited by
-
Clozapine Therapy and COVID-19: A Systematic Review of the Prevalence Rates, Health Outcomes, Hematological Markers, and Patient Perspectives.Schizophr Bull. 2023 Jan 3;49(1):53-67. doi: 10.1093/schbul/sbac148. Schizophr Bull. 2023. PMID: 36242537 Free PMC article.
-
Commentary: Reimagining Community Mental Health Care Services: Case Study of a Need Based Biopsychosocial Response Initiated During Pandemic.Front Psychiatry. 2022 May 27;13:859884. doi: 10.3389/fpsyt.2022.859884. eCollection 2022. Front Psychiatry. 2022. PMID: 35711593 Free PMC article. No abstract available.
-
Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India.Schizophr Res. 2021 Oct;236:38-40. doi: 10.1016/j.schres.2021.08.002. Epub 2021 Aug 7. Schizophr Res. 2021. PMID: 34388517 Free PMC article. No abstract available.
-
A Multi-Dimensional Psychiatric Perspective on the Impact of the COVID-19 Pandemic.Psychiatry Clin Psychopharmacol. 2021 Jun 1;31(2):219-225. doi: 10.5152/pcp.2021.21222. eCollection 2021 Jun. Psychiatry Clin Psychopharmacol. 2021. PMID: 38765226 Free PMC article. Review.
-
The Covid-19 infection: An opportunity to develop systematic vitamin D supplementation in psychiatry.Encephale. 2022 Feb;48(1):102-104. doi: 10.1016/j.encep.2021.02.002. Epub 2021 Mar 14. Encephale. 2022. PMID: 33820650 Free PMC article.
References
-
- Fond G, Salas S, Pauly V, et al. . End-of-life care among the patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database. Lancet Public Health. 2019;4(11):e583–e591. - PubMed
-
- Boudemaghe T, Belhadj I. Data Resource Profile: The French National Uniform Hospital Discharge Data Set Database (PMSI). Int J Epidemiol. 2017;46(2):392–392d. - PubMed
-
- Revon-Rivière G, Pauly V, Baumstarck K, et al. . High-intensity end-of-life care among children, adolescents, and young adults with cancer who die in the hospital: a population-based study from the French national hospital database. Cancer. 2019;125(13):2300–2308. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical